Teladoc Health's Valuation: A Fresh Look After Analyst Upgrades and Earnings Surprise

Teladoc Health (TDOC) has attracted attention after analyst upgrades and stronger-than-expected quarterly results. Despite a 28.22% 90-day share price decline and 38.40% 1-year total shareholder return loss, the company's recent momentum is rebuilding. TDOC is trading at a steep discount to some analyst targets and carrying a long history of share price declines. The current price sits slightly above the most followed fair value estimate of $5.00, raising questions about how much upside is already factored in.